Review



acy1083  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MedChemExpress acy1083
    Select laboratory data
    Acy1083, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acy1083/product/MedChemExpress
    Average 90 stars, based on 1 article reviews
    acy1083 - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock"

    Article Title: Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock

    Journal: Trauma Surgery & Acute Care Open

    doi: 10.1136/tsaco-2019-000321

    Select laboratory data
    Figure Legend Snippet: Select laboratory data

    Techniques Used:

    Effect of each HDACI treatment on HS-induced IL-1β levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of IL-1β in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p=0.0001), and VPA (p<0.05) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the intestine was significantly lower in the animals treated with ACY compared with VPA (p<0.05). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the serum was significantly lower in each of the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; IL-1β, interleukin 1 beta; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).
    Figure Legend Snippet: Effect of each HDACI treatment on HS-induced IL-1β levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of IL-1β in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p=0.0001), and VPA (p<0.05) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the intestine was significantly lower in the animals treated with ACY compared with VPA (p<0.05). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the serum was significantly lower in each of the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; IL-1β, interleukin 1 beta; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Techniques Used: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on HS-induced TNF-α levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of TNF-α in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of TNF-α compared with the vehicle. Expression of TNF-α in the intestine was significantly lower in the animals treated with MC and ACY as compared with VPA (p<0.001). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), and MC+ACY (p<0.001) significantly decreased the expression of TNF-α compared with the vehicle. The expression of TNF-α in the serum was significantly lower in the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; TNF-α, tumor necrosis factor alpha; VPA, valproic acid; * denotes significance between groups (p<0.05).
    Figure Legend Snippet: Effect of each HDACI treatment on HS-induced TNF-α levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of TNF-α in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of TNF-α compared with the vehicle. Expression of TNF-α in the intestine was significantly lower in the animals treated with MC and ACY as compared with VPA (p<0.001). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), and MC+ACY (p<0.001) significantly decreased the expression of TNF-α compared with the vehicle. The expression of TNF-α in the serum was significantly lower in the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; TNF-α, tumor necrosis factor alpha; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Techniques Used: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on HS-induced levels of CINC-1 in the intestine. HS significantly increased the expression of CINC-1 as compared with sham. Treatment with each of MC (p<0.01), ACY (p<0.001), and MC+ACY (p=0.01) significantly decreased intestinal CINC-1 expression compared with the vehicle. There was no significant difference in intestinal CINC-1 expression between the VPA and vehicle groups (p>0.05). ACY, ACY1083; CINC-1, cytokine-induced neutrophil chemoattractant 1; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).
    Figure Legend Snippet: Effect of each HDACI treatment on HS-induced levels of CINC-1 in the intestine. HS significantly increased the expression of CINC-1 as compared with sham. Treatment with each of MC (p<0.01), ACY (p<0.001), and MC+ACY (p=0.01) significantly decreased intestinal CINC-1 expression compared with the vehicle. There was no significant difference in intestinal CINC-1 expression between the VPA and vehicle groups (p>0.05). ACY, ACY1083; CINC-1, cytokine-induced neutrophil chemoattractant 1; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Techniques Used: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on HS-induced intestinal c-caspase 3 expression. HS significantly increased the expression of c-caspase 3 compared with sham. Treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p=0.0003) significantly decreased the levels of c-caspase 3 in the intestine compared with the vehicle. Animals in MC (p=0.01) and ACY (p=0.001) groups had significantly lower levels of c-caspase 3 compared with the VPA group. ACY, ACY1083; c-caspase 3, cleaved caspase 3; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).
    Figure Legend Snippet: Effect of each HDACI treatment on HS-induced intestinal c-caspase 3 expression. HS significantly increased the expression of c-caspase 3 compared with sham. Treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p=0.0003) significantly decreased the levels of c-caspase 3 in the intestine compared with the vehicle. Animals in MC (p=0.01) and ACY (p=0.001) groups had significantly lower levels of c-caspase 3 compared with the VPA group. ACY, ACY1083; c-caspase 3, cleaved caspase 3; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Techniques Used: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on histopathologic evidence of intestinal injury. Hemorrhagic shock resulted in significant blunting and shortening of the villi, capillary congestion, focal epithelial surface necrosis, and infiltration of inflammatory cells in the lamina propria. Treatment with each of the MC (p<0.05), ACY (p<0.05), and MC+ACY (p<0.05) groups attenuated these changes compared with the vehicle. No significant difference was seen between the VPA group and the vehicle group (p=0.4). ACY, ACY1083; HDACI, histone deacetylase inhibitor; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).
    Figure Legend Snippet: Effect of each HDACI treatment on histopathologic evidence of intestinal injury. Hemorrhagic shock resulted in significant blunting and shortening of the villi, capillary congestion, focal epithelial surface necrosis, and infiltration of inflammatory cells in the lamina propria. Treatment with each of the MC (p<0.05), ACY (p<0.05), and MC+ACY (p<0.05) groups attenuated these changes compared with the vehicle. No significant difference was seen between the VPA group and the vehicle group (p=0.4). ACY, ACY1083; HDACI, histone deacetylase inhibitor; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Techniques Used: Histone Deacetylase Assay, Saline



    Similar Products

    acy1083  (MedChemExpress)
    90
    MedChemExpress acy1083
    Select laboratory data
    Acy1083, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/acy1083/product/MedChemExpress
    Average 90 stars, based on 1 article reviews
    acy1083 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Select laboratory data

    Journal: Trauma Surgery & Acute Care Open

    Article Title: Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock

    doi: 10.1136/tsaco-2019-000321

    Figure Lengend Snippet: Select laboratory data

    Article Snippet: After shock, the animals were randomized to the following groups (n=4 per group): (1) sham (anesthetized and cannulated without hemorrhage or treatment), (2) vehicle (250 μL of 0.9% normal saline (NS)), (3) MC1568 (5 mg/kg in DMSO; MedChemExpress, NJ), (4) ACY1083 (30 mg/kg in cyclodextrin; Celgene, Summit, NJ), (5) MC1568+ACY1083 (combination group; 5 mg/kg in DMSO and 30 mg/kg in cyclodextrin, respectively), and (6) VPA (250 mg/kg in 0.9% NS).

    Techniques:

    Effect of each HDACI treatment on HS-induced IL-1β levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of IL-1β in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p=0.0001), and VPA (p<0.05) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the intestine was significantly lower in the animals treated with ACY compared with VPA (p<0.05). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the serum was significantly lower in each of the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; IL-1β, interleukin 1 beta; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Journal: Trauma Surgery & Acute Care Open

    Article Title: Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock

    doi: 10.1136/tsaco-2019-000321

    Figure Lengend Snippet: Effect of each HDACI treatment on HS-induced IL-1β levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of IL-1β in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p=0.0001), and VPA (p<0.05) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the intestine was significantly lower in the animals treated with ACY compared with VPA (p<0.05). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of IL-1β compared with the vehicle. Expression of IL-1β in the serum was significantly lower in each of the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; IL-1β, interleukin 1 beta; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Article Snippet: After shock, the animals were randomized to the following groups (n=4 per group): (1) sham (anesthetized and cannulated without hemorrhage or treatment), (2) vehicle (250 μL of 0.9% normal saline (NS)), (3) MC1568 (5 mg/kg in DMSO; MedChemExpress, NJ), (4) ACY1083 (30 mg/kg in cyclodextrin; Celgene, Summit, NJ), (5) MC1568+ACY1083 (combination group; 5 mg/kg in DMSO and 30 mg/kg in cyclodextrin, respectively), and (6) VPA (250 mg/kg in 0.9% NS).

    Techniques: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on HS-induced TNF-α levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of TNF-α in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of TNF-α compared with the vehicle. Expression of TNF-α in the intestine was significantly lower in the animals treated with MC and ACY as compared with VPA (p<0.001). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), and MC+ACY (p<0.001) significantly decreased the expression of TNF-α compared with the vehicle. The expression of TNF-α in the serum was significantly lower in the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; TNF-α, tumor necrosis factor alpha; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Journal: Trauma Surgery & Acute Care Open

    Article Title: Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock

    doi: 10.1136/tsaco-2019-000321

    Figure Lengend Snippet: Effect of each HDACI treatment on HS-induced TNF-α levels in the (A) intestine and (B) serum. HS resulted in a significant increase in the levels of TNF-α in both the intestine and serum as compared with sham. In the intestine, treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p<0.01) significantly decreased the expression of TNF-α compared with the vehicle. Expression of TNF-α in the intestine was significantly lower in the animals treated with MC and ACY as compared with VPA (p<0.001). In the serum, treatment with MC (p<0.0001), ACY (p<0.0001), and MC+ACY (p<0.001) significantly decreased the expression of TNF-α compared with the vehicle. The expression of TNF-α in the serum was significantly lower in the MC and ACY groups as compared with the VPA group (p<0.01). ACY, ACY1083; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; TNF-α, tumor necrosis factor alpha; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Article Snippet: After shock, the animals were randomized to the following groups (n=4 per group): (1) sham (anesthetized and cannulated without hemorrhage or treatment), (2) vehicle (250 μL of 0.9% normal saline (NS)), (3) MC1568 (5 mg/kg in DMSO; MedChemExpress, NJ), (4) ACY1083 (30 mg/kg in cyclodextrin; Celgene, Summit, NJ), (5) MC1568+ACY1083 (combination group; 5 mg/kg in DMSO and 30 mg/kg in cyclodextrin, respectively), and (6) VPA (250 mg/kg in 0.9% NS).

    Techniques: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on HS-induced levels of CINC-1 in the intestine. HS significantly increased the expression of CINC-1 as compared with sham. Treatment with each of MC (p<0.01), ACY (p<0.001), and MC+ACY (p=0.01) significantly decreased intestinal CINC-1 expression compared with the vehicle. There was no significant difference in intestinal CINC-1 expression between the VPA and vehicle groups (p>0.05). ACY, ACY1083; CINC-1, cytokine-induced neutrophil chemoattractant 1; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Journal: Trauma Surgery & Acute Care Open

    Article Title: Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock

    doi: 10.1136/tsaco-2019-000321

    Figure Lengend Snippet: Effect of each HDACI treatment on HS-induced levels of CINC-1 in the intestine. HS significantly increased the expression of CINC-1 as compared with sham. Treatment with each of MC (p<0.01), ACY (p<0.001), and MC+ACY (p=0.01) significantly decreased intestinal CINC-1 expression compared with the vehicle. There was no significant difference in intestinal CINC-1 expression between the VPA and vehicle groups (p>0.05). ACY, ACY1083; CINC-1, cytokine-induced neutrophil chemoattractant 1; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Article Snippet: After shock, the animals were randomized to the following groups (n=4 per group): (1) sham (anesthetized and cannulated without hemorrhage or treatment), (2) vehicle (250 μL of 0.9% normal saline (NS)), (3) MC1568 (5 mg/kg in DMSO; MedChemExpress, NJ), (4) ACY1083 (30 mg/kg in cyclodextrin; Celgene, Summit, NJ), (5) MC1568+ACY1083 (combination group; 5 mg/kg in DMSO and 30 mg/kg in cyclodextrin, respectively), and (6) VPA (250 mg/kg in 0.9% NS).

    Techniques: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on HS-induced intestinal c-caspase 3 expression. HS significantly increased the expression of c-caspase 3 compared with sham. Treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p=0.0003) significantly decreased the levels of c-caspase 3 in the intestine compared with the vehicle. Animals in MC (p=0.01) and ACY (p=0.001) groups had significantly lower levels of c-caspase 3 compared with the VPA group. ACY, ACY1083; c-caspase 3, cleaved caspase 3; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Journal: Trauma Surgery & Acute Care Open

    Article Title: Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock

    doi: 10.1136/tsaco-2019-000321

    Figure Lengend Snippet: Effect of each HDACI treatment on HS-induced intestinal c-caspase 3 expression. HS significantly increased the expression of c-caspase 3 compared with sham. Treatment with each of MC (p<0.0001), ACY (p<0.0001), MC+ACY (p<0.0001), and VPA (p=0.0003) significantly decreased the levels of c-caspase 3 in the intestine compared with the vehicle. Animals in MC (p=0.01) and ACY (p=0.001) groups had significantly lower levels of c-caspase 3 compared with the VPA group. ACY, ACY1083; c-caspase 3, cleaved caspase 3; HDACI, histone deacetylase inhibitor; HS, hemorrhagic shock; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Article Snippet: After shock, the animals were randomized to the following groups (n=4 per group): (1) sham (anesthetized and cannulated without hemorrhage or treatment), (2) vehicle (250 μL of 0.9% normal saline (NS)), (3) MC1568 (5 mg/kg in DMSO; MedChemExpress, NJ), (4) ACY1083 (30 mg/kg in cyclodextrin; Celgene, Summit, NJ), (5) MC1568+ACY1083 (combination group; 5 mg/kg in DMSO and 30 mg/kg in cyclodextrin, respectively), and (6) VPA (250 mg/kg in 0.9% NS).

    Techniques: Expressing, Histone Deacetylase Assay, Saline

    Effect of each HDACI treatment on histopathologic evidence of intestinal injury. Hemorrhagic shock resulted in significant blunting and shortening of the villi, capillary congestion, focal epithelial surface necrosis, and infiltration of inflammatory cells in the lamina propria. Treatment with each of the MC (p<0.05), ACY (p<0.05), and MC+ACY (p<0.05) groups attenuated these changes compared with the vehicle. No significant difference was seen between the VPA group and the vehicle group (p=0.4). ACY, ACY1083; HDACI, histone deacetylase inhibitor; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Journal: Trauma Surgery & Acute Care Open

    Article Title: Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock

    doi: 10.1136/tsaco-2019-000321

    Figure Lengend Snippet: Effect of each HDACI treatment on histopathologic evidence of intestinal injury. Hemorrhagic shock resulted in significant blunting and shortening of the villi, capillary congestion, focal epithelial surface necrosis, and infiltration of inflammatory cells in the lamina propria. Treatment with each of the MC (p<0.05), ACY (p<0.05), and MC+ACY (p<0.05) groups attenuated these changes compared with the vehicle. No significant difference was seen between the VPA group and the vehicle group (p=0.4). ACY, ACY1083; HDACI, histone deacetylase inhibitor; MC, MC1568; NS, normal saline vehicle; VPA, valproic acid; * denotes significance between groups (p<0.05).

    Article Snippet: After shock, the animals were randomized to the following groups (n=4 per group): (1) sham (anesthetized and cannulated without hemorrhage or treatment), (2) vehicle (250 μL of 0.9% normal saline (NS)), (3) MC1568 (5 mg/kg in DMSO; MedChemExpress, NJ), (4) ACY1083 (30 mg/kg in cyclodextrin; Celgene, Summit, NJ), (5) MC1568+ACY1083 (combination group; 5 mg/kg in DMSO and 30 mg/kg in cyclodextrin, respectively), and (6) VPA (250 mg/kg in 0.9% NS).

    Techniques: Histone Deacetylase Assay, Saline